Literature DB >> 16524862

Rectal administration of propylthiouracil in suppository form in patients with thyrotoxicosis and critical illness: case report and review of literature.

Susan B Zweig1, Jonathan R Schlosser, Sylvia A Thomas, Carol J Levy, Adrienne M Fleckman.   

Abstract

OBJECTIVE: To report the successful management of thyrotoxicosis in a seriously ill 47-year-old man with a perforated gastric ulcer in whom oral intake was contraindicated.
METHODS: Our patient was treated with 400 mg of propylthiouracil (PTU) every 6 hours in the form of specially prepared suppositories for rectal administration, together with intravenously infused esmolol.
RESULTS: We were able to demonstrate substantial absorption of PTU administered by means of rectal suppositories. Serum levels of PTU were maintained within the high therapeutic range for 5 days until the patient was able to tolerate orally administered therapy. The patient improved clinically during this treatment.
CONCLUSION: This case strongly supports the rectal administration of PTU in suppository form as an appropriate alternative route in any patient with thyrotoxicosis, including the critically ill patient, when oral administration is not possible.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524862     DOI: 10.4158/EP.12.1.43

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  4 in total

Review 1.  Thyroid emergencies.

Authors:  Joanna Klubo-Gwiezdzinska; Leonard Wartofsky
Journal:  Med Clin North Am       Date:  2012-02-17       Impact factor: 5.456

2.  A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings.

Authors:  Akilesh Honasoge; Neal Lyons; Kathleen Hesse; Braden Parker; Robert Mokszycki; Kelly Wesselhoff; Rolla Sweis; Erik B Kulstad
Journal:  J Vis Exp       Date:  2016-11-09       Impact factor: 1.355

3.  Thyroid storm precipitated by duodenal ulcer perforation.

Authors:  Shoko Natsuda; Yomi Nakashima; Ichiro Horie; Takao Ando; Atsushi Kawakami
Journal:  Case Rep Endocrinol       Date:  2015-03-09

4.  First Use of a New Device for Administration of Buspirone and Acetaminophen to Suppress Shivering During Therapeutic Hypothermia.

Authors:  Akilesh Honasoge; Braden Parker; Kelly Wesselhoff; Neal Lyons; Erik Kulstad
Journal:  Ther Hypothermia Temp Manag       Date:  2016-01-25       Impact factor: 1.286

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.